{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:39:06Z","timestamp":1791297546899,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bbalip.2009.09.018","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T15:19:39Z","timestamp":1254410379000},"page":"392-399","source":"Crossref","is-referenced-by-count":78,"title":["Drug-induced lipotoxicity: Lipodystrophy associated with HIV-1 infection and antiretroviral treatment"],"prefix":"10.1016","volume":"1801","author":[{"given":"Francesc","family":"Villarroya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2009.09.018_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2009.09.018_bib2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.ijo.0803698","article-title":"Lipodystrophy in HIV 1-infected patients: lessons for obesity research","volume":"31","author":"Villarroya","year":"2007","journal-title":"Int. J. Obes. (Lond)."},{"key":"10.1016\/j.bbalip.2009.09.018_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0192623308327119","article-title":"The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications","volume":"37","author":"Flint","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bbalip.2009.09.018_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350400900206","article-title":"Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations","volume":"9","author":"Gougeon","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.qai.0000176654.97392.c7","article-title":"Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal","volume":"40","author":"Yan","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bbalip.2009.09.018_bib6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1086\/505709","article-title":"Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz","volume":"194","author":"Boyd","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbalip.2009.09.018_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tips.2004.12.005","article-title":"Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity","volume":"26","author":"Villarroya","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbalip.2009.09.018_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/COH.0b013e32810fd785","article-title":"Mechanisms of antiretroviral-induced mitochondrial dysfunction in adipocytes and adipose tissue: in-vitro, animal and human adipose tissue studies","volume":"2","author":"Villarroya","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib9","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1097\/00002030-200411050-00004","article-title":"The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro","volume":"18","author":"Caron","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/meta.2002.34704","article-title":"Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy","volume":"51","author":"Hadigan","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2009.09.018_bib11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib12","doi-asserted-by":"crossref","first-page":"15130","DOI":"10.1074\/jbc.M312875200","article-title":"In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes","volume":"279","author":"El Hadri","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2009.09.018_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF02536052","article-title":"The esterified plasma fatty acid profile is altered in early HIV-1 infection","volume":"28","author":"Peck","year":"1993","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2009.09.018_bib14","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1210\/jc.2002-020892","article-title":"Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure","volume":"87","author":"Van der Valk","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib15","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2006-1174","article-title":"Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia","volume":"91","author":"Hadigan","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/diabetes.50.6.1425","article-title":"The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes","volume":"50","author":"Rudich","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2009.09.018_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350300800509","article-title":"Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes","volume":"8","author":"Janneh","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/joe.0.1720155","article-title":"The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes","volume":"172","author":"Ranganathan","year":"2002","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbalip.2009.09.018_bib19","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/jc.2003-030985","article-title":"Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients","volume":"89","author":"Van der Valk","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib20","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/01.ATV.0000183883.72263.13","article-title":"A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha","volume":"25","author":"Suganami","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2009.09.018_bib21","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1210\/jc.2004-0603","article-title":"Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro","volume":"89","author":"Trujillo","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib22","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1074\/jbc.274.10.6770","article-title":"Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations","volume":"274","author":"Gasic","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2009.09.018_bib23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2009.09.018_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/135965350601100610","article-title":"HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1\/HAART-associated lipodystrophy","volume":"11","author":"Giralt","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib25","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/jc.2002-021600","article-title":"Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices","volume":"88","author":"Tong","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib26","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2009.09.018_bib27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/135965350300800409","article-title":"Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients","volume":"8","author":"Pace","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/MCB.23.3.1085-1094.2003","article-title":"Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone","volume":"23","author":"Wilson-Fritch","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2009.09.018_bib30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2337\/db06-1300","article-title":"Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production","volume":"56","author":"Chevillotte","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2009.09.018_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib32","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1097\/00002030-200409240-00013","article-title":"Adipose tissue expression of IL-18 and HIV-associated lipodystrophy","volume":"18","author":"Lindegaard","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib33","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1152\/ajpendo.90224.2008","article-title":"Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"295","author":"Sevastianova","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/QAD.0b013e3282f56b40","article-title":"Differential gene expression indicates that \u2018'buffalo hump\u2019 is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy","volume":"22","author":"Guallar","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib35","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy","volume":"13","author":"Domingo","year":"1999","journal-title":"AIDS"},{"issue":"Suppl 4","key":"10.1016\/j.bbalip.2009.09.018_bib36","first-page":"A25","article-title":"Genome-wide transcriptomic an\u00e1lisis reveals distinct patterns of altered gene expression in subcutaneous adipose tissue associated with HIV-1 infection, antiretroviral treatment and lipodystrophy","volume":"13","author":"Domingo","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib37","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2009.09.018_bib38","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection","volume":"13","author":"Safrin","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0165-6147(03)00132-9","article-title":"Do regional differences in adipocyte biology provide new pathophysiological insights?","volume":"24","author":"Lafontan","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbalip.2009.09.018_bib40","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2174\/138161207781039599","article-title":"Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?","volume":"13","author":"Rodr\u00edguez","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbalip.2009.09.018_bib41","doi-asserted-by":"crossref","first-page":"E315","DOI":"10.1152\/ajpendo.90486.2008","article-title":"Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes\u2014relevance for partial lipodystrophy","volume":"296","author":"Kovsan","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib42","first-page":"A15","article-title":"Differential alterations of gene expression in visceral versus subcutaneous adipose tissue from HIV-1-infected, HAART-treated patients with lipodystrophy: a pilot study","volume":"13","author":"Villarroya","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u201cBuffalo hump\u201d in men with HIV-1 infection","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2009.09.018_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(05)60293-0","article-title":"Buffalo hump\u201d in HIV-1 infection","volume":"352","author":"Saint-Marc","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2009.09.018_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.qai.0000147527.64863.1a","article-title":"Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia","volume":"38","author":"Mallon","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bbalip.2009.09.018_bib46","first-page":"25","article-title":"Ultrastructural findings consistent with brown adipocytes in buffalo humps of HIV-positive patients with fat redistribution syndrome","volume":"5","author":"Fessel","year":"2000","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib47","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00002030-200404090-00018","article-title":"Uncoupling protein 1 gene expression implicates brown adipocytes in highly active antiretroviral therapy-associated lipomatosis","volume":"18","author":"Rodr\u00edguez de la Concepci\u00f3n","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib48","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2009.09.018_bib49","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2009.09.018_bib50","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2009.09.018_bib51","first-page":"417","article-title":"The importance of brown adipose tissue","volume":"361","author":"Villarroya","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2009.09.018_bib52","first-page":"2430","article-title":"F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients","volume":"18","author":"Bleeker-Rovers","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib53","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00259-009-1126-9","article-title":"Positron emission tomography in patients suffering from HIV-1 infection","volume":"36","author":"Sathekge","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"10.1016\/j.bbalip.2009.09.018_bib54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.1212","article-title":"Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells","volume":"198","author":"Nisoli","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbalip.2009.09.018_bib55","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2009.09.018_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/cs0750021","article-title":"Detection of brown adipose tissue uncoupling protein mRNA in adult patients by a human genomic probe","volume":"75","author":"Bouillaud","year":"1988","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.bbalip.2009.09.018_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2009.09.018_bib58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/135965350501000407","article-title":"Reverse transcriptase inhibitors alter uncoupling protein-1 and mitochondrial biogenesis in brown adipocytes","volume":"10","author":"Rodriguez de la Concepcion","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib59","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbalip.2009.09.018_bib60","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00002030-200211080-00011","article-title":"Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy","volume":"16","author":"Sutinen","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/135965350701200203","article-title":"Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy","volume":"12","author":"Moreno-Torres","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbalip.2009.09.018_bib62","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QAI.0b013e318074efe3","article-title":"HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients","volume":"45","author":"Mohammed","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bbalip.2009.09.018_bib63","doi-asserted-by":"crossref","first-page":"906167","DOI":"10.1155\/2009\/906167","article-title":"PPAR and liver injury in HIV-infected patients","volume":"2009","author":"Lemoine","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.bbalip.2009.09.018_bib64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/0003-4819-115-4-283","article-title":"Fulminant hepatic failure associated with 2\u2032,3\u2032-dideoxyinosine (ddI)","volume":"115","author":"Lai","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbalip.2009.09.018_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbalip.2009.09.018_bib66","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib67","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/japplphysiol.00797.2005","article-title":"Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution","volume":"100","author":"Torriani","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbalip.2009.09.018_bib68","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1152\/ajpendo.00391.2001","article-title":"Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy","volume":"284","author":"Luzi","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib69","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.2337\/diabetes.54.12.3474","article-title":"Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy","volume":"54","author":"Haugaard","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2009.09.018_bib70","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diabetes.50.6.1397","article-title":"The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle","volume":"50","author":"Nolte","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2009.09.018_bib71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1310\/hct0805-345","article-title":"Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients","volume":"8","author":"Maagaard","year":"2007","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.bbalip.2009.09.018_bib72","doi-asserted-by":"crossref","first-page":"E678","DOI":"10.1152\/ajpendo.90287.2008","article-title":"Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance","volume":"295","author":"Abdul-Ghani","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2009.09.018_bib73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/QAI.0b013e31819c291b","article-title":"Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy","volume":"50","author":"Samaras","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bbalip.2009.09.018_bib74","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2005.02223.x","article-title":"beta-Cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy","volume":"62","author":"Haugaard","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10.1016\/j.bbalip.2009.09.018_bib75","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.bbalip.2009.09.018_bib76","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2009.09.018_bib77","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/diabetes.52.7.1695","article-title":"HIV protease inhibitors acutely impair glucose-stimulated insulin release","volume":"52","author":"Koster","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2009.09.018_bib78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/joe.1.05620","article-title":"Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells","volume":"183","author":"Sch\u00fctt","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbalip.2009.09.018_bib79","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1172\/JCI117252","article-title":"Mechanisms of fatty acid-induced inhibition of glucose uptake","volume":"93","author":"Boden","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2009.09.018_bib80","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","article-title":"A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes","volume":"52","author":"Kashyap","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2009.09.018_bib81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00125-004-1347-1","article-title":"Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration","volume":"47","author":"Dubois","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2009.09.018_bib82","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1517\/14656566.8.12.1871","article-title":"Strategies in the treatment of HIV-1-associated adipose redistribution syndromes","volume":"8","author":"del Mar Guti\u00e9rrez","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bbalip.2009.09.018_bib83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/135965350801300107","article-title":"Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113)","volume":"13","author":"Slama","year":"2008","journal-title":"Antivir. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198109002315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198109002315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:35:31Z","timestamp":1685147731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198109002315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1388198109002315"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2009.09.018","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}